Workflow
乳胶导尿管
icon
Search documents
海外华裔大学生海南研习行:感知科创赋能产业新脉动
Zhong Guo Xin Wen Wang· 2025-07-12 07:59
中新网海口7月12日电 (记者 张茜翼)鱼鳞、鱼皮、鱼内脏,能做什么?在海南,一家企业将这些鱼类副 产物资源充分利用,加工成高附加值的营养保健品,产品远销50多个国家和地区。 7月11日,参加2025海外华裔大学生海南研习活动的15名海外华裔大学生走进海口国家高新区,见证海 南自贸港建设下的产业升级与技术创新。 7月11日,参加2025海外华裔大学生海南研习活动的华裔学子走进海口国家高新技术产业开发区,参访 海南华研胶原科技股份有限公司。 中新网记者 骆云飞 摄 在海南华研胶原科技股份有限公司(下称"海南华研")的生物多肽透明车间内,自动化设备高效运转,鱼 胶原蛋白肽的提取、打包一气呵成。原料经过定向酶切、过滤、浓缩等密闭工序后,最终成为干燥的粉 状肽。 本,零关税政策则减少了设备采购费用。"封关后,贸易成本进一步降低,企业能更灵活地拓展全球市 场。" 参加2025海外华裔大学生海南研习活动的华裔学子参访海南维力医疗科技开发有限公司。 中新网记者 骆云飞 摄 在海南维力医疗科技开发有限公司,华裔大学生们参观了自动化的乳胶导尿管生产车间。据该公司总经 理助理杨瑞锦介绍,企业自主研发出自动化生产线,日均产量约30 ...
行进中国|政策“扩区” 企业“增效”
Ren Min Wang· 2025-07-02 07:39
Core Viewpoint - The article highlights the success of Weili Medical Technology Co., Ltd. in leveraging the "processing value-added 30% duty-free policy" in Hainan Free Trade Port, which has significantly boosted its production and market competitiveness [2][4][5]. Company Overview - Weili Medical primarily produces disposable latex catheters, with a production capacity of 300,000 units per day, serving over 3,000 hospitals domestically and exporting to 110 countries and regions [4][8]. - The company has seen its annual output value approach 200 million yuan, with employee numbers growing from fewer than 10 to over 600 [8]. Policy Impact - The "processing value-added 30% duty-free policy" allows companies to enjoy tax exemptions on goods that undergo significant processing in Hainan, effectively reducing procurement costs and enhancing product competitiveness [4][5]. - Since the implementation of this policy, Weili Medical has saved over 3 million yuan in duties [7]. Market Position - Weili Medical has established itself as a significant supplier of medical catheters globally, with a market share ranking among the top in the industry [4][8]. - The company is experiencing strong demand, with orders extending two months ahead, indicating a robust market position [4]. Future Prospects - The company plans to increase investment in new product development and aims to maintain a growth rate of 30%, contributing to the development of the medical device industry in Hainan [8][10]. - Hainan's favorable business environment is seen as a catalyst for innovation and growth within the company [8].